Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.

Guberina N, Pöttgen C, Schuler M, Guberina M, Stamatis G, Plönes T, Metzenmacher M, Theegarten D, Gauler T, Darwiche K, Aigner C, Eberhardt WEE, Stuschke M.

Open source

DOI
10.1186/s13014-022-02080-9
Published
2022-07-16
Container
Radiat Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13014-022-02080-9,
  title = {Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.},
  author = {Guberina N and  Pöttgen C and  Schuler M and  Guberina M and  Stamatis G and  Plönes T and  Metzenmacher M and  Theegarten D and  Gauler T and  Darwiche K and  Aigner C and  Eberhardt WEE and  Stuschke M.},
  year = {2022},
  journal = {Radiat Oncol},
  doi = {10.1186/s13014-022-02080-9},
  url = {https://doi.org/10.1186/s13014-022-02080-9}
}

RIS

TY  - JOUR
TI  - Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.
AU  - Guberina N
AU  -  Pöttgen C
AU  -  Schuler M
AU  -  Guberina M
AU  -  Stamatis G
AU  -  Plönes T
AU  -  Metzenmacher M
AU  -  Theegarten D
AU  -  Gauler T
AU  -  Darwiche K
AU  -  Aigner C
AU  -  Eberhardt WEE
AU  -  Stuschke M.
PY  - 2022
JO  - Radiat Oncol
DO  - 10.1186/s13014-022-02080-9
UR  - https://doi.org/10.1186/s13014-022-02080-9
ER  - 

APA

N, G., C, P., M, S., M, G., G, S., T, P., M, M., D, T., T, G., K, D., C, A., WEE, E., & M., S. (2022). Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.. Radiat Oncol. https://doi.org/10.1186/s13014-022-02080-9

Source records